Dr. Ethan Russo (no relation) is a consultant for GW Pharmaceuticals and a proponent of medical marijuana.

This article is the latest justification that “migraine, fibromyalgia, irritable bowel syndrome, and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines.”

Actually, I changed my mind. I’m not going to summarize it. You can read his entire case for a endocannabinoid deficiency here. Published in 2004, Dr. Russo has been flogging this poor horse for a long time.

The bottom line?
Literature searchers I conducted show no evidence that cannabinoids are useful to treat migraine, fibromyalgia, or irritable bowel syndrome.

4/12/08 19:21 JR

Hi, I’m JR

John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.